119 related articles for article (PubMed ID: 3141672)
1. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.
Hesch RD; Heck J; Delling G; Keck E; Reeve J; Canzler H; Schober O; Harms H; Rittinghaus EF
Klin Wochenschr; 1988 Oct; 66(19):976-84. PubMed ID: 3141672
[TBL] [Abstract][Full Text] [Related]
2. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated according to the ADFR (activation, depression of resorption, formation, repeat the cycle) with parathyroid hormone and diphosphonates (Hannover PTH I study)].
Delling G; Dreyer T; Hahn M; Vogel M; Rittinghaus EF; Hesch RD
Z Orthop Ihre Grenzgeb; 1990; 128(1):1-5. PubMed ID: 2138378
[TBL] [Abstract][Full Text] [Related]
3. Morphological analysis of iliac crest bone biopsies in patients with osteoporosis and treatment according to the ADFR concept with (1-38)hPTH and diphosphonate (EHDP)--Osteoporosis Study I, Hannover.
Delling G; Dreyer T; Vogel M; Hahn M; Rittinghaus EF; Hesch RD
Klin Wochenschr; 1989 May; 67(10):556. PubMed ID: 2500559
[No Abstract] [Full Text] [Related]
4. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
Reeve J; Arlot M; Bernat M; Charhon S; Edouard C; Slovik D; Vismans FJ; Meunier PJ
Metab Bone Dis Relat Res; 1981; 3(1):23-30. PubMed ID: 7266363
[No Abstract] [Full Text] [Related]
5. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
Slovik DM; Neer RM; Potts JT
J Clin Invest; 1981 Nov; 68(5):1261-71. PubMed ID: 7298851
[TBL] [Abstract][Full Text] [Related]
6. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
Lauffenburger T; Olah AJ; Dambacher MA; Guncaga J; Lentner C; Haas HG
Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
[TBL] [Abstract][Full Text] [Related]
7. Human parathyroid peptide treatment of vertebral osteoporosis.
Reeve J; Arlot ME; Bradbeer JN; Hesp R; Mcally E; Meunier PJ; Zanelli JM
Osteoporos Int; 1993; 3 Suppl 1():199-203. PubMed ID: 8461559
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
9. Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
Reeve J; Arlot M; Price TR; Edouard C; Hesp R; Hulme P; Ashby JP; Zanelli JM; Green JR; Tellez M
Eur J Clin Invest; 1987 Oct; 17(5):421-8. PubMed ID: 3121346
[TBL] [Abstract][Full Text] [Related]
10. Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients.
Hodsman AB; Steer BM; Fraher LJ; Drost DJ
Bone Miner; 1991 Jul; 14(1):67-83. PubMed ID: 1868270
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
Kurland ES; Cosman F; McMahon DJ; Rosen CJ; Lindsay R; Bilezikian JP
J Clin Endocrinol Metab; 2000 Sep; 85(9):3069-76. PubMed ID: 10999788
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
[TBL] [Abstract][Full Text] [Related]
13. hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
Reeve J; Bradbeer JN; Arlot M; Davies UM; Green JR; Hampton L; Edouard C; Hesp R; Hulme P; Ashby JP
Osteoporos Int; 1991 Jun; 1(3):162-70. PubMed ID: 1790404
[TBL] [Abstract][Full Text] [Related]
14. Etidronate disodium in postmenopausal osteoporosis.
Heaney RP; Saville PD
Clin Pharmacol Ther; 1976 Nov; 20(5):593-604. PubMed ID: 824086
[TBL] [Abstract][Full Text] [Related]
15. The turnover time of calcium in the exchangeable pools of bone in man and the long-term effect of a parathyroid hormone fragment.
Reeve J
Clin Endocrinol (Oxf); 1978 Jun; 8(6):445-55. PubMed ID: 668151
[TBL] [Abstract][Full Text] [Related]
16. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
Dempster DW; Cosman F; Kurland ES; Zhou H; Nieves J; Woelfert L; Shane E; Plavetić K; Müller R; Bilezikian J; Lindsay R
J Bone Miner Res; 2001 Oct; 16(10):1846-53. PubMed ID: 11585349
[TBL] [Abstract][Full Text] [Related]
17. Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest.
Lockwood DR; Vogel JM; Schneider VS; Hulley SB
J Clin Endocrinol Metab; 1975 Sep; 41(3):533-41. PubMed ID: 169289
[TBL] [Abstract][Full Text] [Related]
18. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
Boyce RW; Paddock CL; Franks AF; Jankowsky ML; Eriksen EF
J Bone Miner Res; 1996 May; 11(5):600-13. PubMed ID: 9157775
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
[TBL] [Abstract][Full Text] [Related]
20. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
Reeve J; Davies UM; Hesp R; McNally E; Katz D
BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
